Skip to main content

Antipsychotic Use in Persons with Dementia

CBE ID
2111
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
1.3 Measure Description

The percentage of individuals 65 years and older with dementia who are receiving an antipsychotic medication without evidence of a psychotic disorder or related condition.

A lower rate indicates better performance.

        • 1.14 Numerator

          The number of individuals from the denominator who had one or more prescription claims and more than 30 days’ supply for any antipsychotic medication AND do not have a diagnosis of schizophrenia, bipolar disorder, Huntington’s disease or Tourette’s Syndrome during the measurement year.

        • 1.15 Denominator

          Individuals 65 years and older as of the first day of the measurement year, meeting continuous enrollment criteria (the measurement year, with one allowable gap), and with at least one of the following during the measurement year:
          • Dementia diagnosis
          • Two or more prescription claims and more than 60 days’ supply for a cholinesterase inhibitor or NMDA receptor antagonist.

        • Exclusions

          N/A

        • 1.13a Data dictionary not attached
          No
        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Neurology Fall Cycle 2019
          Initial Endorsement
          Last Updated
          Removal Date
              • Risk adjustment approach
                Off
                Risk adjustment approach
                Off
                Conceptual model for risk adjustment
                Off
                Conceptual model for risk adjustment
                Off